Capula Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145K Buy
+1,147
New +$151K ﹤0.01% 580
2025
Q4
Sell
-6,009
Closed -$730K 871
2025
Q3
$667K Buy
6,009
+3,123
+108% +$355K ﹤0.01% 411
2025
Q2
$320K Buy
2,886
+1,842
+176% +$196K ﹤0.01% 290
2025
Q1
$117K Buy
+1,044
New +$108K ﹤0.01% 606
2023
Q3
Sell
-60
Closed -$4.62K 569
2023
Q2
$4.62K Sell
60
-1,129
-95% -$90K ﹤0.01% 411
2023
Q1
$98.7K Sell
1,189
-13,251
-92% -$1.1M ﹤0.01% 640
2022
Q4
$1.24M Buy
14,440
+4,109
+40% +$325K 0.02% 376
2022
Q3
$637K Buy
10,331
+8,006
+344% +$505K 0.01% 447
2022
Q2
$144K Buy
+2,325
New +$144K ﹤0.01% 297
2021
Q4
Sell
-7,510
Closed -$525K 425
2021
Q3
$525K Buy
+7,510
New +$528K 0.01% 596
2021
Q2
Sell
-11,576
Closed -$748K 813
2021
Q1
$748K Sell
11,576
-72,794
-86% -$4.69M 0.01% 364
2020
Q4
$4.92M Sell
84,370
-41,691
-33% -$2.52M 0.24% 93
2020
Q3
$7.97M Buy
126,061
+84,971
+207% +$5.89M 1.01% 30
2020
Q2
$3.16M Buy
41,090
+33,129
+416% +$2.54M 0.11% 175
2020
Q1
$595K Sell
7,961
-8,700
-52% -$601K 0.02% 331
2019
Q4
$1.08M Sell
16,661
-128
-0.8% -$8.34K 0.02% 294
2019
Q3
$1.06M Buy
+16,789
New +$1.1M 0.02% 255

Other funds holding GILD

Capula Management's GILD Position: Q2 2026 in Review

Capula Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,147 shares worth $145K. The stake represents ﹤0.01% of the portfolio and ranks #580 among its holdings. This is a return to the name: Capula Management previously reported a position in GILD as recently as Q3 2025.

Capula Management first reported a position in GILD in Q3 2019 and has held it in 17 quarters since. The position peaked at $7.97M in Q3 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capula Management held 1,147 shares of Gilead Sciences worth $145K as of Q2 2026.
  • Gilead Sciences was a new Capula Management position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #580 holding.
  • Capula Management first reported a position in Gilead Sciences in Q3 2019 and has held it in 17 quarters since.
  • Capula Management's Gilead Sciences position peaked at $7.97M in Q3 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.